| Trial ID: | L0372 |
| Source ID: | NCT00324376
|
| Associated Drug: |
Sevelamer Hydrochloride
|
| Title: |
Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Sevelamer hydrochloride
|
| Outcome Measures: |
Primary: Treatment compared on basis of serum phosphorus at end of each treatment and calcium corrected for albumin,calcium-phosphorus product,albumin,iPTH,total,LDL,HDL,non-HDL cholesterol,triglycerides. Safety evaluated on AEs;change in lab values. |
|
| Sponsor/Collaborators: |
Sponsor: Genzyme, a Sanofi Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-03
|
| Completion Date: |
2004-05
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-05
|
| Locations: |
Renal Care Group, Olympia Fields, Illinois, United States|Kidney and Hypertension Center, Cincinnati, Ohio, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00324376
|
